Spinout News
Bioxydyn and QSA partner to provide advanced neurological clinical trials
2 August 2023
UCLB spinout Queen Square Analytics (QSA), has announced a partnership with Bioxydyn, Ltd. to provide advanced clinical trial services in the neurological treatment arena.
The partnership will see Bioxydyn and QSA jointly provide a comprehensive set of clinical trial services for multiple sclerosis (MS) and other neurological disorders.
Bruce Lynn, CEO of Queen Square Analytics Ltd., said: “Bioxydyn provides years of experience and operational capability to QSA’s latest innovations in applying machine learning and other advanced imaging technologies to clinical trials.”